ConductScience.org, home

Paper90168

Phosphonoformate inhibition of visna virus replication.

Sundquist B and 1 other. J Virol, 1979. Cited by 25 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Phosphonoformate inhibition of visna virus replication. Papers, record 90168. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/90168

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phosphonoformate inhibition of visna virus replication.
PubMed
Journal
J Virol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.77
iCite
Revised in PubMed
2020-07-24
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sundquist BB
2Larner EE

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Organophosphorus CompoundsMajor topic
Phosphonoacetic AcidMajor topic
Virus ReplicationMajor topic
Visna-maedi virusMajor topic
Animals
Cell Line
Choroid Plexus
Cytopathogenic Effect, Viral
Reverse Transcriptase Inhibitors
Sheep

Source PubMed

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
2185,798Membrane changes associated with assembly of visna virus.Virology1976https://conductscience.org/library/papers/185798PubMed
3198,587Visna virus RNA synthesis.J Virol1977https://conductscience.org/library/papers/198587PubMed
4206,200Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/206200PubMed
5210,500Trisodium phosphonoformate, a new antiviral compound.Science1978https://conductscience.org/library/papers/210500PubMed
6280,146Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo.Ann N Y Acad Sci1977https://conductscience.org/library/papers/280146PubMed
74,316,300RNA-dependent DNA polymerase in virions of RNA tumour viruses.Nature1970https://conductscience.org/library/papers/4316300PubMed
84,316,301RNA-dependent DNA polymerase in virions of Rous sarcoma virus.Nature1970https://conductscience.org/library/papers/4316301PubMed
956,255The slow infection caused by visna virus.Curr Top Microbiol Immunol1975https://conductscience.org/library/papers/56255PubMed
10727,763Reversible effects on cellular metabolism and proliferation by trisodium phosphonoformate.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/727763PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
7,509,142Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/7509142PubMed
7,046,399The significance of NT1, NT2, and NT3 antigens in epidemiological investigations of bovine group-B streptococcus infections.Acta Vet Scand1981https://conductscience.org/library/papers/7046399PubMed
6,178,013Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.Mol Cell Biochem1982https://conductscience.org/library/papers/6178013PubMed
6,166,282Goat visna virus: isolation of a retrovirus related to visna virus of sheep.Arch Virol1981https://conductscience.org/library/papers/6166282PubMed
3,435,102Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3435102PubMed
2,942,386Antiviral drugs for AIDS. Current status and future prospects.Drugs1986https://conductscience.org/library/papers/2942386PubMed
2,824,170Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.Drugs1987https://conductscience.org/library/papers/2824170PubMed
2,680,436Antiviral therapy in human immunodeficiency virus infection.Drugs1989https://conductscience.org/library/papers/2680436PubMed
2,445,282Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/2445282PubMed
2,425,731PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/2425731PubMed
2,141,779Age-related differences in pharmacokinetics of phosphonoformate in cats.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2141779PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/90168

GET https://conductscience.org/api/papers/v1/90168/authors